National Institutes of Health clinical trial of universal flu vaccine candidate began
On Sept. 15, 2023, researchers at the National Institute of Allergy and Infectious Diseases announced they had begun…
Newly discovered trigger of Parkinsonï¾’s upends common beliefs
On Sept. 15, 2023, a Northwestern Medicine study challenges a common belief in what triggers Parkinsonï¾’s disease. Degeneration…
WHO reported legionellosis deaths from Poland
On Sept. 14, 2023, the World Health Organization (WHO) reported that as of Sept. 11, 2023, a total…
Northwestern received $50 million to study life sciences using mathematics
On Sept. 14, 2023, Northwestern University announcealberta_innovates_logo.pngd it had been awarded $50 million over five years from the…
Biotechnology | Disease | Life Science News | Medicine | NIH | Therapeutics
NIH awarded $50.3 million for ‘multi-omics’ research on human health and disease
On Sept. 12, 2023, the National Institutes of Health announced it was establishing the Multi-Omics for Health and…
Moderna received U.S. FDA approval for updated COVID-19 vaccine
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
Pfizer and BioNTech received U.S. FDA approval for 2023-2024 COVID-19 vaccine
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Oncology | Radiology | Therapeutics | Women's Health
High levels of particulate air pollution associated with increased breast cancer incidence
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…
White House announced $240 million in additional investment to accelerate new ways to prevent, detect, treat cancer
On Sept. 10, 2023, the White House announced $240 million in additional investment through the Advanced Research Projects…
![European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older](https://www.lifesciencehistory.com/wp-content/uploads/2022/08/european_commission_logo-768x768.jpg){kind=logo}
European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
The Markey Cancer Center became an NCI-designated Comprehensive Cancer Center
On Sept. 6, 2023, the Markey Cancer Center (MCC) became Kentucky’s first and only National Cancer Institute (NCI)-Designated…
Biotechnology | COVID-19 | FDA | Life Science News | Vaccine
Moderna clinical trial data confirmed updated Covid-19 vaccine generated strong immune response against BA.2.86 variant
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
OHSU achieved national milestone in new knee repair technique
On Sept. 6, 2023, Oregon Health & Science University (OHSU) announced it had achieved a landmark in orthopaedic…
USDA broke ground on new Plant Research Facility on North Carolina State University campus
On Sept. 6, 2023, the U.S. Department of Agriculture’s Agricultural Research Service and NC State University’s College of…
NIH investigated multidrug-resistant bacterium emerging in community settings
On Sept. 6, 2023, the National Institutes of Health (NIH) announced it was investgating ‘hypervirulent’ strains of the…
Avian influenza outbreak impacted shorebirds and seals near Fort Flagler State Park in Washington
On Sept. 1, 2023, the Washington State Department of Health announced an outbreak of avian influenza, also known…
CDC awarded $279 million to 49 States, DC, and 40 local health departments to help prevent drug overdoses
On Sept. 1, 2023, the U.S. Centers for Disease Control and Prevention (CDC) awarded $279 million to 49…
North Dakota Development Fund invested $3 million in Colossal Biosciences and Mammoth de-extinction
On Sept. 1, 2023, the North Dakota Development Fund, an investment vehicle for the North Dakota Department of…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
FDA Cleared 23andMe improved BRCA report for communities underrepresented in genetic testing
On Aug. 31, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the updated 23andMe Personal…
Results from single-dose psilocybin randomized clinical trial treatment for major depressive disorder published in JAMA
On Aug. 31, 2023, study results published in JAMA found that psilocybin treatment was associated with a clinically…
Emergentsï¾’ NARCANï¾® Nasal Spray launched OTC making it possible for everyone to help save a life from an opioid overdose Emergency
On Aug. 30, 2023, Emergent BioSolutions announced NARCANï¾® Naloxone HCl Nasal Spray 4 mg would be available on…
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
WHO initiative signed new licensing agreements on COVID-19 technologies
On Aug. 29, 2023, the COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual…
CTE identified in brain donations from young amateur athletes
On Aug. 28, 2023, in a study of 152 deceased athletes less than 30 years old who were…
MIT and two California universities received $50 million grant for Army research
On Aug. 27, 2003, The Institute for Collaborative Biotechnologies (ICB) announced it was funding a $50 million five…
Eye cell atlas pinpoints where disease-causing genes are expressed, raising hope for inroads against blindness
On Aug. 25, 2023, Harvardï¾’s Center for Brain Science announced the ceation of an eye atlas that pinpoints…
CDC’s ACIP announced vaccines recommendation for 2023ï¾–24 seasonal influenza
On Aug. 25. 2023, the Advisory Committee on Immunization Practices (ACIP) published new recommendations by the Advisory Committee…
U.S. FDA approved first biosimilar to treat Multiple Sclerosis
On Aug. 24, 2023, the U.S. Food and Drug Administration approved Sandoz’s Tyruko (natalizumab-sztn), the first biosimilar to…
NIAID-funded study traced evolution of Malaria drug resistance in East Africa
On Aug. 24, 2023, NIAID reported that emerging resistance to common malaria treatments in Uganda could be connected…
City of Hope received $32 million grant to advance novel therapies
On Aug. 24, 2023, researchers at City of Hope announced were awarded $32.3 million from the California Institute…